These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14761911)

  • 1. Is there a role for isolated limb perfusion with tumor necrosis factor in patients with melanoma?
    De Wilt JH; Thompson JF
    Ann Surg Oncol; 2004 Feb; 11(2):119-21. PubMed ID: 14761911
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
    Deroose JP; Eggermont AM; van Geel AN; Verhoef C
    Curr Opin Oncol; 2011 Mar; 23(2):183-8. PubMed ID: 21150602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage.
    Eggermont AM; Brunstein F; Grünhagen D; ten Hagen TL
    Ann Oncol; 2004; 15 Suppl 4():iv107-12. PubMed ID: 15477292
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases.
    Rossi CR; Foletto M; Mocellin S; Pilati P; Lise M
    Ann Surg Oncol; 2004 Feb; 11(2):173-7. PubMed ID: 14761920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
    Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
    Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
    Vaglini M; Santinami M; Manzi R; Inglese MG; Santoro N; Persiani L; Belli F
    Melanoma Res; 1994 Mar; 4 Suppl 1():35-8. PubMed ID: 8038594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.
    Bartlett DL; Ma G; Alexander HR; Libutti SK; Fraker DL
    Cancer; 1997 Dec; 80(11):2084-90. PubMed ID: 9392330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
    Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
    Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
    Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial experiences with isolated limb perfusion for unresectable melanoma of the limb.
    Romics L; Dy EA; Coffey JC; Herlihy D; Aftab F; Chaudhry MZ; Fogarty K; O'Donnell JA; Redmond HP
    Ir J Med Sci; 2011 Jun; 180(2):517-20. PubMed ID: 21287291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
    Kam PC; Thompson JF
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
    Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
    Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion.
    Pigozzo J; De Rossi C; Rossi CR; Nitti D; Sileni VC
    Melanoma Res; 2009 Jun; 19(3):193-4. PubMed ID: 19436179
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?
    Hoekstra HJ; Veerman K; van Ginkel RJ
    J Surg Oncol; 2014 Mar; 109(4):338-47. PubMed ID: 24403098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic isolated limb perfusion (ILP) in the management of patients with advanced or recurrent limb melanoma.
    Khan MA; Lanitis S; Desai AP; Rosin RD
    Ir J Med Sci; 2012 Mar; 181(1):157. PubMed ID: 21959950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.